BEXIMCO PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.5 GBX | 0.00% |
|
-1.35% | -12.05% |
| Mar. 04 | Beximco names Iqbal Ahmed as managing director | AN |
| Jan. 30 | Beximco Pharmaceuticals to strengthen portfolio as interim profit up | AN |
Quotes 5-day view
Delayed Quote London S.E.| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 37 p | 36.5 p | 36.5 p | 36.5 p |
| Volume | 23 201 | 10 477 | 5 473 | 105 000 |
| Change | 0.00% | -1.35% | 0.00% | 0.00% |
| Opening | 37.00 | 36.50 | 36.50 | 36.50 |
| High | 38.00 | 36.55 | 36.47 | 36.50 |
| Low | 36.50 | 36.55 | 36.47 | 36.00 |
Performance
| 1 week | -1.35% | ||
| Current month | -6.41% | ||
| 1 month | -7.59% | ||
| 3 months | +4.29% | ||
| 6 months | -2.67% | ||
| Current year | -12.05% | ||
| 1 year | -13.10% | ||
| 3 years | -57.56% | ||
| 5 years | -18.89% | ||
| 10 years | +226.17% |
Volumes
marketsDaily volume
105 000
Estimated daily volume
105 000
Avg. Volume 20 sessions
34 320
Daily volume ratio
3.06
Avg. Volume 20 sessions GBX
1 252 680.00
Avg. Volume 20 sessions USD
1 252 680.00
Record volume 1
9 900 448
Record volume 2
9 697 647
Record volume 3
8 733 346
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (GBX)
51 876 023 755
Capitalization (USD)
471 708 684
Net sales (BDT)
39 266 662 240
Net sales (USD)
357 051 760
Number of employees
5 700
Sales / Employee (BDT)
6 888 888
Sales / Employee (USD)
62 641
Free-Float
76.68 %
Free-Float capitalization (GBX)
39 780 926 777
Free-Float capitalization (USD)
361 727 967
Average Daily Capital Traded
0%
Highs and lows
1 week
36.00
38.00
1 month
35.0040.00
Current year
33.5642.00
1 year
33.3045.00
3 years
33.30131.00
5 years
28.07131.00
10 years
10.10131.00
Indicators
Moving average 5 days
36.70
Moving average 20 days
36.98
Moving average 50 days
38.65
Moving average 100 days
39.03
Price spread / (MMA5)
+0.55%
Price spread / (MMA20)
+1.30%
Price spread / (MMA50)
+5.89%
Price spread / (MMA100)
+6.94%
STIM
RSI 9 days
31.21
RSI 14 days
32.51
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | -1.35% | -12.05% | -13.10% | 472M | ||
| +1.19% | +0.99% | +25.83% | +94.94% | 661B | ||
| +2.28% | +2.36% | +27.00% | +59.58% | 566B | ||
| -0.46% | -1.20% | -6.76% | -10.13% | 352B | ||
| +0.37% | +4.31% | +20.34% | +15.67% | 332B | ||
| -4.58% | -4.08% | +3.00% | -1.35% | 283B | ||
| -0.32% | +9.52% | +13.09% | +1.22% | 231B | ||
| -0.56% | +4.64% | +5.46% | -2.36% | 200B | ||
| +1.01% | -0.50% | -9.61% | -19.53% | 195B | ||
| +0.22% | +0.39% | -6.26% | +13.06% | 145B | ||
| +0.55% | -2.31% | -11.77% | -34.25% | 144B | ||
| -0.43% | +4.99% | +1.64% | -11.00% | 122B | ||
| +0.34% | -8.34% | -12.59% | -34.06% | 90.92B | ||
| +0.76% | +3.38% | +13.98% | +14.62% | 84.13B | ||
| +0.23% | -2.01% | -19.24% | -21.88% | 81.58B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | +0.29% | +0.92% | +2.14% | +3.43% | ||
| Weighted average by Cap. | +0.45% | +1.32% | +10.29% | +24.57% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -12.05% | ||
| 2023 | -23.15% | ||
| 2022 | -55.56% | ||
| 2021 | +21.50% | ||
| 2020 | +139.13% | ||
| 2019 | +2.22% | ||
| 2018 | -25.00% | ||
| 2017 | +7.14% | ||
| 2016 | +121.89% | ||
| 2015 | +54.58% | ||
| 2014 | +37.46% | ||
| 2013 | -11.54% | ||
| 2012 | -16.00% | ||
| 2011 | -34.26% | ||
| 2010 | +93.04% | ||
| 2009 | +158.48% | ||
| 2008 | -61.35% | ||
| 2007 | -40.92% | ||
| 2006 | -6.24% | ||
| 2005 | +2.77% |
- Stock Market
- Equities
- BXPHARMA Stock
- BXP Stock
- Quotes Beximco Pharmaceuticals Limited
